Skip to content

Hypofractionated radiotherapy for the palliation of patients with advanced head and neck cancer who are unsuitable for an attempt at curative treatment

Assessment of quality of life of patients undergoing hypofractionated radiotherapy for the palliation of patients with advanced head and neck cancer who are unsuitable for an attempt at curative treatment

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12605000114640
Enrollment
40
Registered
2005-08-09
Start date
2004-08-17
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Hypofractionated radiotherapy, 30 Gray in 5 fractions, optional 6th 5 Gray fraction.

Sponsors

Dr Sandro Porceddu
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
0 to No maximum
Healthy volunteers
No

Inclusion criteria

Biopsy proven squamus cell carcinoma (primary or regional nodal disease) of the head and neck, ineligible for curative treatment, performance status 0-2, life expectanccy of at least 4 months, written informed consent.

Exclusion criteria

No exclusion criteria

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026